New more sensitive diagnostics protect transplanted kidney
With new more sensitive diagnostics, rejection of a transplanted kidney can be detected earlier,...
Event I June 10-13, 2023
The European Human Genetics Conference 2023 (ESHG)
Next Generation Sequencing: Changing the game in CFTR analysis
This whitepaper is authored by Stewart Payne, Consultant Clinical Scientist at UK National Health Service and Head of Molecular Genetics in the North West Thames Regional Genetics since 1995. Stewart’s laboratory was one of few in the UK offering CFTR whole gene analysis by Sanger sequencing and has recently translated whole gene analysis to next generation sequencing.
- How NGS enables routine screening of all published CFTR mutations.
- Categories of CFTR mutations and interpretation of CFTR mutation data.
- What the future holds for CFTR diagnostics and targeted therapies.
How can we help your lab?
Cost-effective solution
IVDR-certified test kits are often more cost-effective than alternative solutions, such as developing your own in-house LDTs. By choosing an IVDR-certified product, you can save time and resources while still receiving the highest-quality results.
Increased efficiency
IVDR-certified test kits are designed to be user-friendly and efficient, saving you time and resources in your laboratory operations and improving patient outcomes.
Compliance with regulations
With the implementation of the IVDR, buying IVDR-certified test kits is essential for compliance with European Union regulations. By purchasing from a trusted provider, you can be confident that you are meeting all the necessary requirements and avoiding costly penalties.
At the end of the day, it is all about ensuring safety and accuracy for patients.
Webinar on-demand | February 16, 2023
Post-transplant monitoring: The future of chimerism testingNews | January 25-26, 2023
We are attending the Festival of Genomics & Biodata!Podcast | December 6, 2022
Collaborations and homebrew assays by Dan Hauzenberger & Turid Sundin Carlsson
Early relapse prediction after allogeneic hematopoietic stem cell transplantation for acute lymphoblastic leukemia (ALL) using lineage-specific chimerism analysis
Hematopoietic stem cell transplantation (HSCT) is the only curative treatment for patients with...
Assessment of Chimerism Testing by Next Generation Sequencing
Relapse of the underlying malignant disease is a major complication after hematopoietic stem cell...
Characteristics of a chimerism NGS assay with unmatched sensitivity